Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cardiac muscle tissue regeneration refers to the process by which damaged or lost heart muscle (myocardium) is replaced or repaired, restoring cardiac function. In adult humans and most mammals, this regenerative capacity is extremely limited; after injury such as myocardial infarction, the heart typically forms scar tissue rather than regenerating functional myocardium. However, certain vertebrates like zebrafish and newts can regenerate their hearts throughout life by proliferating existing cardiomyocytes. Key mechanisms involve cardiomyocyte proliferation, partial de-differentiation, progenitor cell activation, and metabolic reprogramming. Several signaling pathways (FGF/p38 MAPK inhibition; Periostin; NRG1; Nodal/BMP/Wnt) regulate these processes. Tissue engineering approaches are also being developed using human pluripotent stem cell-derived cardiomyocytes. Understanding these mechanisms is central to developing therapies aimed at true myocardial repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cardiac Muscle Tissue Regeneration.